Flovent Diskus 250

   
Google
 
Web NewDrugInformation.com

Flovent Diskus 250


Drug - Flovent Diskus 250
The trade name of the product as shown on the labeling.

Dosage - POWDER; INHALATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Fluticasone Propionate
Multiple ingredients are in alphabetical order.

Strength - 0.25MG/INH
The potency of the active ingredient(s), Fluticasone Propionate. May repeat for multiple part products.

Applicant - GLAXOSMITHKLINE
The firm name holding legal responsibility for Flovent Diskus 250. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020833
The FDA assigned number to Flovent Diskus 250. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Flovent Diskus 250. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 29, 2000
The date Flovent Diskus 250 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Flovent Diskus 250. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Flovent Diskus 250 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Glaxosmithkline
The full name of the firm holding legal responsibility for the new application of Flovent Diskus 250.

Flovent Diskus 250